On assessing survival benefit of immunotherapy using long‐term restricted mean survival time (Q61029)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: On assessing survival benefit of immunotherapy using long‐term restricted mean survival time |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | On assessing survival benefit of immunotherapy using long‐term restricted mean survival time |
scientific article |
Statements
42
0 references
8
0 references
1139-1155
0 references
18 January 2023
0 references
